SCHEMBL1857722

SCHEMBL1857722

CC(=O)Nc1cccc(C=O)n1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
LMNA P02545 1/20 0.57
MAPK8 P45983 1/20 0.51
RAB9A P51151 1/20 0.44
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
ADORA3 P0DMS8 3/20 0.42
FGFR4 P22455 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADORA1 P30542 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HPGD P15428 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA2A P29274 1/20 0.41
CDK5 Q00535 1/20 0.40
DYRK1A Q13627 1/20 0.40
CDK5R1 Q15078 1/20 0.40
GRM5 P41594 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29957412 1.00 KDM4E (0.57) KDM4ELMNAMAPK8RAB9AHSP90AA1
SCHEMBL13376698 0.84 KDM4E (0.56) KDM4ELMNAMAPK8RAB9AHSP90AA1
SCHEMBL1857957 0.84 RAB9A (0.46) KDM4ELMNARAB9AFGFR4SMN1; SMN2
SCHEMBL821844 0.82 KDM4E (0.71) KDM4ELMNAMAPK8RAB9AHSP90AA1
SCHEMBL9000763 0.81 KDM4E (0.53) KDM4ELMNAMAPK8RAB9AHSP90AA1
SCHEMBL1857075 0.81 ADORA1 (0.44) KDM4ELMNARAB9AFGFR4SMN1; SMN2
SCHEMBL29951716 0.78 ALDH1A1 (0.44) KDM4ELMNAMAPK8RAB9AHSP90AA1
SCHEMBL13596267 0.78 LCK (0.41) RAB9AFGFR4MEN1KMT2ACDK5
SCHEMBL29426670 0.78 LCK (0.41) RAB9AFGFR4MEN1KMT2ACDK5
SCHEMBL20588932 0.77 KCNH2 (0.44) FGFR4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105566-A1 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2011-05-05 US claimed
CN-101977504-A Fungicide hydroximoyl-tetrazole derivatives BAYER CROPSCIENCE SA 2011-02-16 CN claimed
EP-2265118-A2 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES Bayer CropScience AG (DE) 2010-12-29 EP claimed
WO-2009115557-A2 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES BAYER CROPSCIENCE SA (FR) 2009-09-24 WO claimed
CN-101977504-B Fungicide hydroximoyl-tetrazole derivatives BAYER CROPSCIENCE SA 2014-11-26 CN disclosed
US-8466176-B2 Fungicide hydroximoyl-tetrazole derivatives BAYER CROPSCIENCE AG (DE) 2013-06-18 US disclosed
US-20110105566-A1 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2011-05-05 US disclosed
CN-101977504-A Fungicide hydroximoyl-tetrazole derivatives BAYER CROPSCIENCE SA 2011-02-16 CN disclosed
EP-2265118-A2 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES Bayer CropScience AG (DE) 2010-12-29 EP disclosed
WO-2009115557-A2 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES BAYER CROPSCIENCE SA (FR) 2009-09-24 WO disclosed
US-20050038035-A1 Heterocyclic amide compounds as apolipoprotein b inhibitors DAISO CO., LTD. (JP) 2005-02-17 US disclosed
EP-1472226-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-03 EP disclosed
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2003045921-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-05 WO disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105566-A1 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES HAAO, CYP51A1, HPD KDM4E 622/4885LMNA 3100/4885MAPK8 2732/4885
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 KDM4E 3114/4885LMNA 1239/4885MAPK8 3144/4885
US-20050038035-A1 Heterocyclic amide compounds as apolipoprotein b inhibitors APOB, APOL1, CTRB2 KDM4E 2286/4885LMNA 629/4885MAPK8 3701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.